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The anticonidial activity of human monocytes deactivated by cytokines interleukin (lL)-4 and
IL-10 and the hormone dexamethasone was studied and compared with antilisterial activity. Dexa-
methasone had the largest effect on the anticonidial activity and suppressed germination-inhibiting
activity and elimination of ingested spores by macrophages more than the cytokines did. Maximally
active concentrations of IL-10 had a similar but significantly smaller deactivating effect. IL-4, in
contrast to IL-lO and dexamethasone, did not reduce anticonidial activity. However, IL-4 and IL-
10 were equally potent in deactivating human macrophages against Listeria monocytogenes, whereas
dexamethasone was significantly less potent in the Listeria model. These observations indicate that
all three mediators lessen antimicrobial activity but that this effect depends on the test organism
studied and is apparently mediated through regulation of different antimicrobial systems operating
against a particular microorganism.
Macrophages take a central role in natural resistance to co-
nidia from Aspergillus species as well as Listeria monocyto-
genes in experimental and presumably also natural infection
[1-3]. Human macrophages derived from blood monocytes
are highly efficient in controlling both organisms, even in the
absence ofactivation by cytokines, but they lose their capability
to kill these microorganisms and to suppress their growth when
exposed to pharmacologic concentrations of glucocorticoids
[4]. Previous studies from our laboratory have shown that dexa-
methasone apparently interferes with nonoxidative killing sys-
tems of resting human macrophages, but the nature of these
systems is unknown [4, 5].
In the present study, we compared the effects of dexametha-
sone as well as interleukin (IL )-4 and IL-l 0, two other media-
tors of deactivation [6], on the activity of human macrophages
against L. monocytogenes and Aspergillus fumigatus.
Materials and Methods
Organisms. A strain of A. fumigatus from previous studies
was used for all experiments, and single-spore suspensions were
prepared as described [4]. For challenge, conidia were directly
diluted in complete medium at a concentration of 2 X 105 spores/
mL. L. monocytogenes EGD was cultured and prepared as de-
scribed [5].
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Cell cultures. Human monocyte cultures were obtained after
gradient separation of mononuclear cells from heparinized blood
from healthy volunteers as described [5, 7]. Monolayers of mono-
cytes on 12-mm glass coverslips, freed from contaminating lym-
phocytes by washing away nonadherent cells, were placed in 35-
mm tissue culture dishes (Falcon Plastics, Oxnard, CA) containing
four coverslips each with 30,000-40,000 monocytes with a purity
of >98% in 2 mL of complete medium [7]. Culture conditions
were 37°C, 98% humidity, and 5% CO 2 . Complete medium was
Medium 199 (GISCO Europe, Basel, Switzerland) supplemented
with 25% pooled normal human serum. A single lot of pooled
serum stored in aliquots at -70°C was used throughout the experi-
ments.
Cytokine supplements. Human recombinant IL-4 was from
Schering-Plough (Kenilworth, NJ) and was used in a final concen-
tration of 1 ng/mL. Human recombinant IL-IO was from Pepro-
Tech (Rocky Hill, NJ) and used in a final concentration of 5 ng/
mL. Human recombinant tumor necrosis factor-a (TNF-a) was
from Knoll (Ludwigshafen, Germany). The three cytokines were
dissolved in PBS and then diluted in medium. Dexamethasone
(Sigma, St. Louis) was dissolved at a concentration of 2.5 X 10-2
M in ethanol before dilution in medium to a final concentration of
2.5 X 10-7 M. All cytokines and dexamethasone have been shown
in dose-finding studies to be maximally active at these concentra-
tions [7]. Appropriate solvent controls were added to control cul-
tures at the same time as the supplements.
Tests for antimicrobial activity. Anticonidial activity was as-
sessed as described [4]. In brief, germination of phagocytized
spores was enumerated 18 h after challenge of monolayers that
had been pretreated for 36 h with the indicated cytokines on
Giemsa-stained coverslips [4]. Germination rates of control spores
incubated in cell-free complete medium was always >99%. The
analysis of germination rates was based on 4x 200 spores from
quadruplicate wells per condition and experiment.
Disappearance of spores by digestion was quantitated by enu-
merating the decrease in spores on the basis of phagocytic index
immediately after phagocytosis and removal of noningested spores
by washing and incubation for 18 h as described [8]. This analysis
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was based on 4x 400 macrophages from quadruplicate wells per
condition and experiment and time point.
Antilisterial activity was assessed as described [4, 5] by follow-
ing the percentage of mononuclear phagocytes harboring bacteria
during an incubation period of 7 h after phagocytosis and washing
off non -cell-associated bacteria. After non-cell-associated bacte-
ria or conidia were washed off, dexamethasone and cytokines were
again added to cultures at the indicated concentrations. Of note,
IL-I, IL-4, and dexamethasone did not affect the phagocytic index,
as shown previously [7].
Measurement ofH202 secretion and NO production. HzOz se-
cretion in response to phorbol myristate acetate stimulation was
measured by chemiluminescence as described [5]. NO was mea-
sured as nitrite accumulation during 24 h with the Griess reagent
as described [9].
Statistical analysis. Mean and SE (combined data from several
experiments) or SD (single experiments) are given. Bonferroni's
correction for multiple comparisons and Dunnett's test for compar-
ison of multiple samples with one control were done using a com-
puter-based program (lnstat; Graphpad, San Diego).
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Results
Deactivation of anticonidial activity. Dexamethasone was
most potent in deactivating anticonidial activity of human
monocytes, followed by IL-IO. IL-4 had no effect on anticonid-
ial activity (figure I). Assessment of the anticonidial activity
by quantification of germination rates of spores 18 h after
phagocytosis or digestion of spores during phagocytosis for 18
h can be done in parallel. However, anticonidial activity can
probably be even more accurately determined by quantification
of the percentage of spores germinating in relation to the spores
originally ingested by macrophages (i.e., percentage of spores
germinating at 18 h of incubation among number of spores
remaining at 18 h plus number of spores digested during 18 h
of incubation). In any event, all three methods of assessment
indicated that dexamethasone was more potent than IL-I0 in
deactivating macrophages and that IL-4 had no effect on antico-
nidial activity.
Comparison ofdeactivation ofantilisterial and anticonidial
activity and relation to NO production and H 202 secretion.
In contrast to results from experiments with A. fumigatus, anti-
listerial activity was most strongly reduced by IL-4 and IL-
10; dexamethasone had a much lower activity than the tested
cytokines (table 1, P < .001). Furthermore TNF-a, which did
not restore anticonidial activity of macrophages deactivated
with any of the three tested mediators of deactivation, signifi-
cantly increased antilisterial activity in macrophages deacti-
vated with IL-I0 and IL-4 (table 1). During the experiments,
no detectable amount of nitrite accumulated in supernatants of
phagocytes before challenge with the microorganisms or after.
Only deactivation by IL-l 0 was associated with a significantly
decreased secretion of Hz0 2 during the respiratory burst (ta-
ble 1).
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Figure 1. Anticonidial activity of control monocytes and mono-
cytes exposed for 36 h before challenge to dexamethasone (Dexa),
interleukin (IL)-lO, or IL-4. Concentrations were for dexamethasone,
2.5 X 10- 5 M; IL-l 0, 5 ng/mL; and IL-4, 1 ng/mL. A, No. of phagocy-
tized conidia completely digested by phagocytes during 18 h of incu-
bation. B, Absolute germination rate of phagocytized spores (% of
spores germinating among no. of spores enumerated in phagocytes).
C, Corrected germination rate (% of conidia germinating among no.
of spores enumerated in phagocytes + no. of spores digested). Data
are mean ± SE from 5 independent experiments with quadruplicate
values from quadruplicate wells for controls and each of 3 tested
mediators of deactivation per experiment. A-C, Control vs. dexa-
methasone and IL-lO, P < .001; control vs. IL-4, P > .05. A, Dexa-
methasone vs. IL-IO, P > .05. B, Dexamethasone vs. IL-lO, P <
.01. C, Dexamethasone vs. IL-IO, P < .05.
Discussion
In these studies, mediators of macrophage deactivation (IL-
10, IL-4, dexamethasone) affected different phagocytic effector
systems differently, and deactivation characterized by assess-
ment of antimicrobial activity depended on the test organism
studied. The most probable explanation for this finding is that,
in human mononuclear phagocytes, disparate effector mecha-
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Table 1. Effect of macrophage-deactivating agents on parameters for macrophage activity.
Deactivating agent
None
(control) Dexamethasone IL-10 IL-4
Germination inhibition of conidia
from Aspergillus fumigatus (%) 74.7 ± 1.3 24.9 ± 0.7* 54.7 ± 8.2* 75.8 ± 2.0 t
Germination inhibition of conidia
after TNF-0' (%) 67.8 ± 5.9 20.6 ± 5.9 46.6 ± 2.0 t 82.1 ± 4.5 t
Change in % of cells infected with
Listeria monocytogenes (%) -24.0 ± 2.5 -0.66 ± 16.6 i 25.0 ± 2.8* 31.3 ± 3.5*
Change in % of cells infected with
L. monocytogenes after TNF-O'
(%) -42.0 ± 1.2 -5.3 ± 7.0* -26.3 ± 5.7 t -0.6 ± 2.1 *
H20 2 secretion (pmol/l O'' cells) 136 ± 24 132 ± 6t 68 ± 2* 119 ± 8t
Nitrite production (J.LmoIl106 cells) <0.1 <0.1 <0.1 <0.1
NOTE. Data are mean ± SD from typical experiment. IL, interleukin; TNF, tumor necrosis factor. Germination
rates of conidia were enumerated 18 h after challenge. Antilisterial activity was assessed by quantifying % of cells
eliminating bacteria or acquiring bacteria during incubation for 7 h after phagocytosis.
P *<.001, t>.05, i<.Ol vs. control in same row.
nisms are responsible for the control of different microorgan-
isms. Accordingly, an effect on a single antimicrobial system
by a deactivating mediator cannot explain the observed changes
in the antimicrobial activities. No NO-producing activity that
could explain antilisterial or anticonidial activity was detected.
The capacity to produce reactive oxygen intermediates (ROI)
did not explain all the observed effects, particularly in view of
our previous finding that neither killing of conidia nor intracel-
lular control of L. monocytogenes by nonactivated human mac-
rophages depends on ROI generation [4, 5]. On the other hand,
conidia from A. fumigatus are resistant to oxidative killing [1,
4]; yet IL-IO that halved H-O, secretion evidently reduced
anticonidial activity by affecting nonoxidative antimicrobial
systems as well.
Suppression of TNF-a secretion has been proposed to ex-
plain the failure of deactivated macrophages to control intracel-
lular parasites [10]. However, in the present fungal studies,
exogenous TNF-a could not restore anticonidial activity.
Therefore, taken together, effects of deactivating mediators
on previously undescribed effector functions of human macro-
phages must be assumed to explain deactivation of anticonidial
activity.
In this context, the recent proposition that aspergillosis might
be promoted by glucocorticoids through a direct effect on fun-
gal growth is noteworthy [11]. We have previously appropri-
ately controlled for such effects in our experiments that as-
sessed germination rates in macrophages exposed to
glucocorticoids [1, 4]. By demonstrating that glucocorticoids
affect killing and digestion of conidia as well as germination
rates, we further substantiate that the glucocorticoid target is
the macrophage rather than the fungal spore in this setting.
Such a mechanism is therefore also eliminated as explanation
for the success of conidia in resisting glucocorticoid-treated
macrophages.
In conclusion, the balancing effects of activating and deacti-
vating signals appear to depend not only on the complexity of
a network of simultaneous or sequential activating and deacti-
vating mediators [10, 12] but also on the specific microbial
pathogen and the antimicrobial mechanism operative in their
control.
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Synthesis of Tumor Necrosis Factor-a mRNA in Bronchoalveolar Lavage Cells
from Human Immunodeficiency Virus-Infected Persons with Pneumocystis
carinii Pneumonia
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Departments oj Immunology and Sexually Transmitted Diseases,
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Bronchoalveolar lavage fluid cells from a cohort of 34 human immunodeficiency virus-infected
persons with established Pneumocystis carinii pneumonia were examined for expression of tumor
necrosis factor-a (TNF-a) mRNA by fluorescence in situ hybridization with an antisense riboprobe.
Video image analysis was used to develop a quantitative assay that evaluates relative single-cell
levels of mRNA. The resulting data were analyzed as an antisense-to-sense ratio and examined for
correlation between TNF-a mRNA expression and other measures of disease severity. Higher levels
of TNF-a mRNA were seen in persons who had higher levels of arterial oxygen.
Pulmonary manifestations are important in determining mor-
bidity and mortality resulting from human immunodeficiency
virus (HIV) infection. Increased susceptibility to opportunistic
pulmonary infection was recognized when the clinical syn-
drome associated with HIV was first defined, and many caus-
ative organisms have been identified. Perhaps the best-known
example is Pneumocystis carinii. However, as with other HIV-
associated disease, the pathophysiologic mechanism that leads
to pulmonary manifestations and the relationship between find-
ings and outcome (e.g., lung function, patient survival) remain
poorly understood.
Bronchoalveolar lavage (BAL) specimens have provided
much information for diagnosis and research investigation of
these conditions. Such studies indicate that identifiable oppor-
tunistic disease may be only one form of lung immunopathol-
Received 13 February 1996; revised I May 1996.
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ogy in such patients. For example, 25%-50% of all HIV-
infected persons show some evidence of alveolitis [1], and a
mixed NK and other T cell (chiefly CD8 cells) infiltration has
been noted, not only early but also late in the course of HIV
disease, when responder cells are depleted [2]. In the lung, the
conventional selective target cell for HIV infection, the CD4
T cell, has not been found in appreciable numbers, probably
reflecting the progressive dysfunction and eventual depletion
of these cells.
The alternative CD4 target cells, mononuclear phagocytes
(MP), are present in the lung in the form of alveolar macro-
phages (AM), and absolute numbers of these cells may be
increased in both early stages of infection and late stages of
disease [3]. This may be due to relative resistance to cytopathic
effects of HIV; therefore, MP may serve not only as a potential
reservoir for HIV but also as a primary vector for viral propaga-
tion [4]. Both viral propagation in MP and the effector-immu-
noregulatory function of MP are mediated by cytokines, and
studies of cytokine production, either by protein detection or
polymerase chain reaction (PCR) [5], have shown that in HIV-
infected persons there may be dysregulation of several cyto-
kines, including tumor necrosis factor-a (TNF-a).
TNF-a plays a pivotal role as a mediator in many physiologic
and immunologic processes. In the lung, the AM is the first host
cell to interact with infectious agents and to synthesize cytokines
(such as TNF-rr) that may modulate the ensuing inflammatory
response, thus serving both as a potential reservoir and as a "la-
tent" source of cytokines. TNF-a released by AM may have
